Qing Ling Yu
Director Ejecutivo en Beijing Advaccine Biotechnology Co., Ltd. .
Perfil
Qing Ling Yu is currently the President, General Manager & Executive Director at Beijing Advaccine Biotechnology Co., Ltd.
Prior to this, she obtained an undergraduate degree from the University of International Business & Economics in 2001.
Cargos activos de Qing Ling Yu
Empresas | Cargo | Inicio |
---|---|---|
Beijing Advaccine Biotechnology Co., Ltd.
Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | Director Ejecutivo | 08/04/2009 |
Formación de Qing Ling Yu.
University of International Business & Economics | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
Health Technology |
- Bolsa de valores
- Insiders
- Qing Ling Yu